Immix Biopharma, Inc. (NASDAQ:IMMX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nancy Chang Other companies: Galera Therapeutics, Inc. (Director · Since at least Dec 30, 2024); W&T Offshore, Inc. (Director · Since at least Apr 28, 2023); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); SciClone Pharmaceuticals Inc (Director · Sep 17, 2013 – Oct 13, 2017 · Past); Charles River Laboratories International, Inc. (Director · Oct 24, 2007 – May 7, 2010 · Past); Tanox Inc (Director · Dec 31, 2005 – Nov 2, 2006 · Past) | Independent Director · Since at least Sep 8, 2025 |
| Magda Marquet Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Jun 15, 2026) | Director · Since at least May 22, 2026 |
| Yekaterina Chudnovsky Other companies: Elicio Therapeutics, Inc. (Director · Since at least Jun 1, 2023) | Independent Director · Since at least Aug 22, 2023 |
| Carey Ng | Independent Director · Since at least Dec 15, 2021 |
| David He | Head of Technical Operations · Since at least Nov 4, 2026 |
| David Marks | Chief Medical Officer · Since at least Nov 5, 2026 |
| Gabriel Morris | President and Chief Financial Officer · Since at least Jul 14, 2022 |
| Graham Ross | CMO & Head of Clinical Dev. · Dec 15, 2021 – Dec 15, 2021 · Past |
| Helen Adams | Director · Since at least May 15, 2024 |
| Ilya Rachman | Chief Executive and Scientific Officer · Since at least Dec 15, 2021 |
| Jane Buchan | Director · Since at least May 22, 2026 |
| Jason Hsu | Independent Director · Since at least Dec 15, 2021 |
| Michael Grabow | Chief Commercial Officer · Since at least Nov 12, 2025 |
| Vladimir P Torchilin | Scientific Co-Founder · Dec 15, 2021 – Dec 20, 2021 · Past |